Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:59:31 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:RPRX from 2023-05-07 to 2024-05-06 - 25 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-19 08:15U:RPRXNews ReleaseRoyalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
2024-04-17 08:15U:RPRXNews ReleaseRoyalty Pharma Declares Second Quarter 2024 Dividend
2024-02-28 16:15U:RPRXNews ReleaseRoyalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference
2024-02-15 07:30U:RPRXNews ReleaseRoyalty Pharma Reports Q4 and Full Year 2023 Results
2024-01-30 16:15U:RPRXNews ReleaseRoyalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
2024-01-19 08:15U:RPRXNews ReleaseRoyalty Pharma Announces Dividend Increase
2024-01-08 07:00U:RPRXNews ReleaseRoyalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
2023-11-27 16:15U:RPRXNews ReleaseRoyalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
2023-11-13 08:10U:RPRXNews ReleaseRoyalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
2023-11-13 08:00U:RPRXNews ReleaseTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
2023-11-08 07:00U:RPRXNews ReleaseRoyalty Pharma Reports Third Quarter 2023 Results
2023-10-19 07:59U:RPRXNews ReleaseRoyalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics ¢ € ™ Royalty on Evrysdi
2023-10-16 16:15U:RPRXNews ReleaseRoyalty Pharma Declares Fourth Quarter 2023 Dividend
2023-10-11 16:15U:RPRXNews ReleaseRoyalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
2023-09-21 08:25U:RPRXNews ReleaseRoyalty Pharma Appoints Eric Schneider as Chief Technology Officer
2023-09-05 16:15U:RPRXNews ReleaseRoyalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
2023-09-05 16:01U:RPRXNews ReleaseAscendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
2023-09-05 08:25U:RPRXNews ReleaseRoyalty Pharma to Present at Upcoming Investor Conferences
2023-08-24 06:30U:RPRXNews ReleaseRoyalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin ‚ ® (Nadofaragene Firadenovec-Vncg)
2023-08-24 01:15U:RPRXNews ReleaseRoyalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin ‚ ® (nadofaragene firadenovec-vncg)
2023-08-08 07:00U:RPRXNews ReleaseRoyalty Pharma Reports Second Quarter 2023 Results
2023-07-18 16:15U:RPRXNews ReleaseRoyalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023
2023-07-17 16:15U:RPRXNews ReleaseRoyalty Pharma Declares Third Quarter 2023 Dividend
2023-06-07 08:15U:RPRXNews ReleaseRoyalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
2023-05-09 07:00U:RPRXNews ReleaseRoyalty Pharma Reports First Quarter 2023 Results